Evaluation of Satisfaction in Patients Receiving PegIntron [peginterferon alfa-2b] Pen/Rebetol [ribavirin] for Hepatitis C in Slovenia
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 26 Aug 2009
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 22 Jul 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2008 New trial record.